Compound of general Formula (I): wherein: n: 1-5 m: 0, 1, or 2 z: 0 or 1 L: =CH 2 -, =CH 2 CH 2 - or A: is wherein R 1 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 2 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 3 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 4 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 5 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, or a pharmaceutically acceptable salt, hydrate or solvate thereof; in the form of a pure diastereoisomer or as a mixture of diastereomers, in the form of a pure enantiomer or as a mixture of enantiomers. n: 1-5 m: 0, 1, or 2 z: 0 or 1 L: =CH 2 -, =CH 2 CH 2 - or A: is wherein R 1 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 2 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 3 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu, or i-Bu, R 4 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 5 : H, Me, Et, i-Pr, t-Bu, i-Bu, CN, F, Cl, Br, CF 3 , CH 2 CF 2 , cyclopropyl, cyclobutyl, cyclopentyl, SR 6 , OR 6 or NR 6 R 7 R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, or a pharmaceutically acceptable salt, hydrate or solvate thereof; in the form of a pure diastereoisomer or as a mixture of diastereomers, in the form of a pure enantiomer or as a mixture of enantiomers. R 6 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, R 7 : H, Me, Et, n-Pr, i-Pr, t-Bu or i-Bu, <EOS>